Skip to main content

January 2024 Vol 17, No 1

Navigating today’s healthcare system can be challenging for anyone, but for older adults, it can be especially difficult. From scheduling appointments to engaging with clinicians to interpreting health insurance coverage, trying to secure the best medical care can be overwhelming, resulting in poor clinical outcomes, emotional distress, and reduced quality of life. Read More ›

Artificial intelligence (AI) chatbots showed mixed results when it came to providing treatment strategies and direct-to-patient cancer advice for a variety of malignancies, according to 2 studies recently published in JAMA Oncology. Read More ›

Madrid, Spain—A perioperative regimen of neoadjuvant nivolumab (Opdivo) plus chemotherapy followed by surgery and adjuvant nivolumab demonstrated a statistically significant and clinically meaningful improvement in event-free survival (EFS) versus neoadjuvant chemotherapy plus placebo followed by surgery and adjuvant placebo in patients with resectable non–small cell lung cancer. Read More ›